FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology, immunology and medicine, particularly to polypeptides and their therapeutic use for treating stress syndromes, immune response and stroke.
EFFECT: invention provides peptides with antagonist activity against natural CXCR4.
11 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODIES SPECIFIC FOR CD70 AND THEIR USE | 2019 |
|
RU2801093C2 |
CHIMERIC CYTOKINE RECEPTOR | 2016 |
|
RU2826122C1 |
DISPLAY OF AN INTEGRAL MEMBRANE PROTEIN ON EXTRACELLULAR ENVELOPED POXVIRUS VIRIONS | 2017 |
|
RU2759846C2 |
CHIMERIC ANTIGENE RECEPTORS TARGETTING FLT3 | 2018 |
|
RU2820859C2 |
MUC16-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USE | 2019 |
|
RU2795198C2 |
CONJUGATES OF ANTIBODY TO CCR7 AND DRUG | 2018 |
|
RU2777662C2 |
CD20 THERAPY, CD22 THERAPY AND COMBINATION THERAPY WITH CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR (CAR) K CD19 | 2016 |
|
RU2752918C2 |
CHIMERIC ANTIGENE RECEPTOR | 2019 |
|
RU2810092C2 |
MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USE | 2020 |
|
RU2815388C2 |
CHIMERIC ANTIGEN RECEPTORS FOR CANCER TREATMENT | 2017 |
|
RU2826270C2 |
Authors
Dates
2024-08-12—Published
2019-11-08—Filed